Agonist and antagonist modulation of [S-35]-GTP gamma S binding in transfected CHO cells expressing the neurotensin receptor

被引:22
作者
Hermans, E [1 ]
Geurts, M [1 ]
Maloteaux, JM [1 ]
机构
[1] UNIV CATHOLIQUE LOUVAIN,PHARMACOL LAB,B-1200 BRUSSELS,BELGIUM
关键词
neurotensin; SR-48692; U-73122; S-35]-GTP gamma S; G-protein;
D O I
10.1038/sj.bjp.0701334
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The functional interaction of the cloned rat neurotensin receptor with intracellular G-proteins was investigated by studying the binding of the radiolabelled guanylyl nucleotide analogue [S-35]-GTP gamma S induced by neurotensin to membranes prepared from transfected Chinese hamster ovary (CHO) cells. 2 The agonist-induced binding of [S-35]-GTP gamma S was only detected in the presence of NaCl in the incubation buffer. However, it was also demonstrated that the binding of [H-3]-neurotensin to its receptor was inhibited by NaCl. In the presence of 50 mM NaCl, the binding of the labelled nucleotide was about 2 fold increased by stimulation with saturating concentrations of neurotensin (EC50 value of 2.3 +/- 0.9 nM). 3 The stimulation of [S-35]-GTP gamma S binding by neurotensin was mimicked by the stable analogue of neurotensin, JMV-449 (EC50 value of 1.7 +/- 0.4 nM) and the neurotensin related peptide neuromedin N (EC50 value of 21 +/- 6 nM). 4 The NT-induced [S-35]-GTP gamma S binding was competitively inhibited by SR48692 (pA(2) value of 9.55 +/- 0.28), a non-peptide neurotensin receptor antagonist. SR48692 alone had no effect on the specific binding of [S-35]-GTP gamma S. 5 The response to neurotensin was found to be inhibited by the aminosteroid U-73122, a putative inhibitor of phospholipase C-dependent processes, indicating that this drug may act at the G-protein level. 6 Taken together, these results constitute the first characterization of the exchange of guanylyl nucleotides at the G-protein level that is induced by the neuropeptide neurotensin after binding to its receptor.
引用
收藏
页码:1817 / 1823
页数:7
相关论文
共 50 条
[31]   BINDING AND INTERNALIZATION OF IODINATED NEUROTENSIN IN NEURONAL CULTURES FROM EMBRYONIC MOUSE-BRAIN [J].
MAZELLA, J ;
LEONARD, K ;
CHABRY, J ;
KITABGI, P ;
VINCENT, JP ;
BEAUDET, A .
BRAIN RESEARCH, 1991, 564 (02) :249-255
[32]   NEUROMEDIN-N - A NOVEL NEUROTENSIN-LIKE PEPTIDE IDENTIFIED IN PORCINE SPINAL-CORD [J].
MINAMINO, N ;
KANGAWA, K ;
MATSUO, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 122 (02) :542-549
[33]  
NANOFF C, 1995, MOL PHARMACOL, V48, P806
[34]   SR-48692, A NONPEPTIDE NEUROTENSIN RECEPTOR ANTAGONIST, BLOCKS THE CARDIOVASCULAR EFFECTS ELICITED BY NEUROTENSIN IN GUINEA-PIGS [J].
NISATO, D ;
GUIRAUDOU, P ;
BARTHELEMY, G ;
GULLY, D ;
LEFUR, G .
LIFE SCIENCES, 1994, 54 (07) :PL95-PL100
[35]   CHARACTERIZATION OF THE EFFECT OF SR48692 ON INOSITOL MONOPHOSPHATE, CYCLIC-GMP AND CYCLIC-AMP RESPONSES LINKED TO NEUROTENSIN RECEPTOR ACTIVATION IN NEURONAL AND NONNEURONAL CELLS [J].
OURYDONAT, F ;
THURNEYSSEN, O ;
GONALONS, N ;
FORGEZ, P ;
GULLY, D ;
LEFUR, G ;
SOUBRIE, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (02) :1899-1905
[36]   DIFFERENTIAL-EFFECTS OF THE NONPEPTIDE NEUROTENSIN ANTAGONIST, SR-48692, ON THE PHARMACOLOGICAL EFFECTS OF NEUROTENSIN AGONISTS [J].
PUGSLEY, TA ;
AKUNNE, HC ;
WHETZEL, SZ ;
DEMATTOS, S ;
CORBIN, AE ;
WILEY, JN ;
WUSTROW, DJ ;
WISE, LD ;
HEFFNER, TG .
PEPTIDES, 1995, 16 (01) :37-44
[37]   THE OXIME HGG-12 AS A MUSCARINIC ACETYLCHOLINE-RECEPTOR ANTAGONIST WITHOUT INTRINSIC ACTIVITY IN CARDIAC MEMBRANES [J].
REITHMANN, C ;
BERGER, HJ ;
HILF, G ;
WERDAN, K .
ARCHIVES OF TOXICOLOGY, 1991, 65 (06) :518-523
[38]   CHARACTERIZATION AND VISUALIZATION OF NEUROTENSIN BINDING TO RECEPTOR-SITES IN HUMAN-BRAIN [J].
SADOUL, JL ;
KITABGI, P ;
ROSTENE, W ;
JAVOYAGID, F ;
AGID, Y ;
VINCENT, JP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (01) :206-213
[39]   HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS EXPRESS HIGH-AFFINITY NEUROTENSIN RECEPTORS COUPLED TO INTRACELLULAR CALCIUM-RELEASE [J].
SCHAEFFER, P ;
LAPLACE, MC ;
SAVI, P ;
PFLIEGER, AM ;
GULLY, D ;
HERBERT, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (07) :3409-3413
[40]  
SLUSHER BS, 1994, MOL PHARMACOL, V46, P115